Kolon TissueGene (950160) is drawing investors' attention as it continues to plunge for the fourth consecutive trading day. With the cumulative decline over the short term reaching 60%, both the possibility of a rebound next week and the potential for expanded volatility are being discussed simultaneously.

Additional 28% Decline on the 24th... Closes at 15,000 Won

Kolon TissueGene closed at 15,000 won on the 24th, down 28.74% (6,050 won) from the previous trading day. During the session, it dropped to as low as 14,750 won before recovering some of its losses toward the end of trading.

The recent pace of decline in the stock price has been steep. Starting from a closing price of 42,900 won on the 21st, it fell to 30,050 won on the 22nd, 21,050 won on the 23rd, and 15,000 won on the 24th, dropping nearly by half in just four trading days. The stock had also declined on the 16th (-20.28%) and the 20th (-1.45%), indicating that the downward trend has persisted over the past week.

Overall Market Weakness Also a Factor

On the same day, the broader domestic stock market declined sharply due to risk-off sentiment driven by escalating geopolitical tensions between the United States and Iran. The KOSPI closed at 6,690.62 (-406.27p, -5.72%) and the KOSDAQ at 748.22 (-42.06p, -5.32%), reflecting shrinking investor confidence.

Bargain Hunting vs. Expanded Volatility

In the market, attention is focused on whether bargain-hunting buying will flow in given the magnitude of the short-term decline. However, some analyses suggest that the possibility of further volatility expansion should also be monitored.

[This article is not intended to solicit investment. All final investment decisions and responsibilities lie with the individual investor.]